Gilead Sciences to Present at the 25th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 8th; Webcast Available Through Gilead Corporate Website

FOSTER CITY, Calif.--(BUSINESS WIRE)--June 7, 2004--Gilead Sciences, Inc. (Nasdaq:GILD) announced today that its corporate presentation will be webcast from the 25th Annual Goldman Sachs Global Healthcare Conference in Dana Point, California. This webcast may be accessed via the company's corporate website at www.gilead.com.

John Milligan, PhD, Gilead's Executive Vice President and Chief Financial Officer, will provide an overview of the company and an update on key business milestones on Tuesday, June 8, 2004 at 2:00 p.m. Pacific Time.

To access the live webcast via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the live presentation to ensure adequate time for any software download that may be necessary to view the webcast.

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases worldwide. The company has six marketed products and focuses its research and clinical programs on anti-infectives. Headquartered in Foster City, CA, Gilead has operations in the United States, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

CONTACT: Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715 (Investor Relations)

SOURCE: Gilead Sciences, Inc.